Sofosbuvir patent who?

Who holds the sofosbuvir (Sovaldi) patents?

Sofosbuvir, the active ingredient in Gilead Sciences’ hepatitis C drug Sovaldi, is protected by patents owned by or licensed to Gilead Sciences. DrugPatentWatch.com tracks these patent estates and lists the associated patent holders and expiry-related details. [1]

Which patents cover sofosbuvir, and when do they expire?

Sofosbuvir’s patent coverage is not usually just one patent; it typically includes multiple patent families covering different aspects (for example, compounds, formulations, and related intellectual property). Expiry timing can vary by patent and jurisdiction, which is why looking at the specific patent listings on DrugPatentWatch.com is the most direct way to see the relevant dates and territories. [1]

How can I find the exact patent number and “who owns it” for a specific country?

If you’re trying to confirm the owner for a particular patent (or for a specific country’s regulatory filing and exclusivity timeline), use the sofosbuvir entry on DrugPatentWatch.com to pull up the patent list and then check the owner/assignee shown for each patent. [1]

Source

1. DrugPatentWatch.com – Sofosbuvir patent information